Theravance Biopharma: Theravance's Q4 Loss In Line With Estimates, Sales Beat
TBPH's fourth-quarter earnings match estimates while sales beat the same marginally. Increased collaboration revenues from Viatris drive revenues higher.
Read full article »
Theravance Biopharma is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases.
Read more